Public Health England is urging all men and women over the age of 60 to get screened for bowel cancer, after fresh data show over 40 percent are not getting tested, “putting thousands unnecessarily at risk of dying”.
Specialty pharma Medicis Health has launched two new products in the UK approved for relief and protection against possible serious skin problems in patients receiving treatment for cancer and multiple sclerosis.
Shares in Innate Pharma plunged near 50 percent on Thursday after it said that a combination of lirilumab and Bristol-Myers Squibb's PD-1 inhibitor Opdivo failed to provide clear evidence of benefit in patients with squamous cell carcinoma of the head and neck.
Online GP consultation systems “may not be the silver bullet for reducing GP workload and patient waiting times that government policymakers are hoping for,” according to University of Bristol researchers.
Chancellor Philip Hammond’s Autumn Budget has promised an extra £2.8 billion for NHS services over the next three years, though the amount falls well short of the £4 billion deemed by health leaders as necessary to retain the current quality of services.
European regulators have cleared Tesaro’s Zejula, offering a new option for the maintenance treatment of certain adults with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer.